您好,欢迎访问中国热带农业科学院 机构知识库!

The Beneficial Effects of Two Polysaccharide Fractions from Sargassum fusiform against Diabetes Mellitus Accompanied by Dyslipidemia in Rats and Their Underlying Mechanisms

文献类型: 外文期刊

作者: Jia, Rui-Bo 1 ; Wu, Juan 2 ; Luo, Donghui 1 ; Lin, Lianzhu 1 ; Chen, Chong 4 ; Xiao, Chuqiao 1 ; Zhao, Mouming 2 ;

作者机构: 1.Chaozhou Branch Chem & Chem Engn Guangdong Lab, Chaozhou 521000, Peoples R China

2.South China Univ Technol, Sch Food Sci & Engn, Guangzhou 510640, Peoples R China

3.Guangdong Ocean Univ, Sch Food Sci & Engn, Yangjiang 529500, Peoples R China

4.Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Hainan Key Lab Storage & Proc Fruits & Vegetables, Zhanjiang 524001, Peoples R China

关键词: Sargassum fusiform polysaccharides; antidiabetic activities; underlying mechanisms

期刊名称:FOODS ( 影响因子:5.561; 五年影响因子:5.94 )

ISSN:

年卷期: 2022 年 11 卷 10 期

页码:

收录情况: SCI

摘要: The current study aimed to assess the anti-diabetic effects and potential mechanisms of two Sargassum fusiform polysaccharide fractions (SFPs, named SFP-1 and SFP-2). The carbohydrate-loading experiment revealed that SFP-2 could control postprandial hyperglycemia by inhibiting the activity of digestive enzymes in rats. The analysis of diabetic symptoms and serum profiles indicated that SFPs could mitigate diabetes accompanied by dyslipidemia, and SFP-2 showed better regulatory effects on body weight, food intake and the levels of total cholesterol (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C) and free fatty acid (FFA) in diabetic rats. Intestinal bacterial analysis showed that SFP treatment could reshape the gut flora of diabetic rats, and SFP-2 possessed a greater regulatory effect on the growth of Lactobacillus and Blautia than SFP-1. RT-qPCR analysis revealed that SFPs could regulate the genes involved in the absorption and utilization of blood glucose, hepatic glucose production and lipid metabolism, and the effects of SFP-2 on the relative expressions of Protein kinase B (Akt), Glucose-6-phosphatase (G-6-Pase), Glucose transporter 2 (GLUT2), AMP-activated protein kinase-alpha (AMPK alpha), Peroxisome proliferator-activated receptor gamma (PPAR gamma) and Cholesterol 7-alpha hydroxylase (CYP7A1) were greater than SFP-1. All above results indicated that SFPs could be exploited as functional foods or pharmaceutical supplements for the treatment of diabetes and its complications.

  • 相关文献
作者其他论文 更多>>